The U.S. Food and Drug Administration has introduced new guidelines aimed at enhancing transparency in TV drug advertisements. These rules, effective from November 20, require drugmakers to provide clearer and more direct information regarding their medications' risks and side effects. The FDA spent over 15 years developing these guidelines to eliminate industry practices that minimize or divert attention from risk information.
While many companies have already adopted the new rules, concerns have arisen about the rise of pharma influencers promoting drugs online with limited oversight. A proposed bill in Congress seeks to compel the FDA to more rigorously monitor such promotions on social media platforms.
